Plasma adhesion and inflammation markers: Asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients

Obesity Surgery

Volumn 17, Issue 5, 2007, Pages 672-678

  Konukoglu, Dildar ^a   Uzun, Hafize ^a   Firtina, Sinem ^a   Arica, Pinar Çigdem ^a   Kocael, Ahmet ^a   Taskin, Mustafa ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Endothelial dysfunction; Inflammation; Laparoscopic adjustable gastric banding; Morbid obesity

Indexed keywords

C REACTIVE PROTEIN; DIMETHYLARGININASE; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPASE A2; VASCULAR CELL ADHESION MOLECULE 1;

ADHESION; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COLORIMETRY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; MALE; METABOLISM; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; ARGININE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; COHORT STUDIES; FEMALE; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; OBESITY, MORBID; PHOSPHOLIPASES A; WEIGHT LOSS;

EID: 34250750178     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9113-3     Document Type: Article

References (32)

1. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-75.
2. Vendrell J, Broch M, Vilarrasa N et.al Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962-71.
3. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-92.
4. Cooke JP. ADMA: its role in vascular disease. Vasc Med 2005; 10 (Suppl 1): S11-S17.
5. Mulvihill NT, Foley JB, Crean P et al. Prediction of cardiovascular risk using soluble cell adhesion molecules. Eur Heart J 2002; 23: 1569-74.
6. Szmitko PE, Wang CH, Weisel RD et al. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 2003; 108: 2041-8.
7. Kougias P, Chai H, Lin PH et al. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit 2006; 12: RA5-RA16.
8. Ballantyne CM, Hoogeveen RC, Bang H et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004; 109: 837-42.
9. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195-200.
10. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Development Conference Draft Statement. Obes Surg 1991; 1: 257-66.
11. Eisenberg D, Duffy AJ, Bell RL. Update on obesity surgery. World J Gastroenterol 2006; 12: 3196-203.
12. Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med 2005; 10 (Suppl 1): S35-S43.
13. Konukoglu D, Serin O, Turhan MS. Plasma leptin and its relationship with lipid peroxidation and nitric oxide in obese female patients with or without hypertension. Arch Med Res 2006; 37: 602-6.
14. Boger RH, Bode-Boger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-7.
15. McLaughlin T, Stuhlinger M, Lamendola C et al. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 2006; 91: 1896-900.
16. Stuhlinger MC, Abbasi F, Chu JW et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002; 287: 1420-6.
17. Jiang JL, Jiang DJ, Tang YH et al. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol Sin 2004; 25: 893-901.
18. Tietge UJ, Pratico D, Ding T et al. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. J Lipid Res 2005; 46: 1604-14.
19. Jia SJ, Jiang DJ, Hu CP et al. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol 2006; 44: 143-8.
20. Zhang J, Rui YC, Yang PY et al. C-reactive protein induced expression of adhesion molecules in cultured cerebral microvascular endothelial cells. Life Sci 2006; 78: 2983-8.
21. Pearson TA, Mensah GA, Alexander RW et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
22. Albert MA, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med 2004; 5 (Suppl 3): S22-S27.
23. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-9.
24. Vazquez LA, Pazos F, Berrazueta JR et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90: 316-22.
25. Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055-60.
26. Krzyzanowska K, Mittermayer F, Kopp HP et al. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 2004; 89: 6277-81.
27. Kopp HP, Kopp CW, Festa A et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042-7.
28. Gasteyger C, Suter M, Calmes JM et al. Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding. Obes Surg 2006; 16: 243-50.
29. Cottam DR, Schaefer PA, Shaftan GW et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes Surg 2002; 12: 335-42.
30. Pontiroli AE, Pizzocri P, Koprivec D et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 2004; 150: 195-200.
31. Hanusch-Enserer U, Cauza E, Spak M et al. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 2004; 12: 284-91.
32. Uzun H, Zengin K, Taskin M et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 2004; 14: 659-65.